Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

4

Revenue 2017

Herceptin

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Herceptin was produced by Roche.

Biologic or biosimilar: what are prescribers thinking?

Biologic or biosimilar: what are prescribers thinking? Herceptin has been around for 12–13 years. Biosimilars are new drugs; we don’t have the same data for them.

Mylan gets first biosimilar Herceptin OK from FDA

Mylan gets first biosimilar Herceptin OK from FDA Mylan has become the first pharma company to win US approval for a biosimilar of Roche’s big-selling cancer antibody Herceptin. ... have suggested it will start making revenues from the drug in 2019 – the year in which Roche’s US patent on

First Herceptin biosimilar cleared in Europe

First Herceptin biosimilar cleared in Europe means it can now threaten the CHF 2.1bn in European sales achieved by Herceptin last year. ... Roche is claiming patent protection for Herceptin in the US out to 2019, but its EU patents expired in 2014.

Building a bright future

Building a bright future Herceptin while taking a buffeting over trading in the US, despite European growth contributing strongly to $2.96bn second quarter revenues. ... mission.”. It has manoeuvered into pole position to grab a significant slice of Roche’s $2bn-a-year

CHMP backs maintenance therapy for Tesaro's Zejula

CHMP backs maintenance therapy for Tesaro's Zejula The CHMP recommended approval of two biosimilars, namely Samsung Bioepis' Ontruzant (trastuzumab) - the first biosimilar of Roche's breast cancer therapy Herceptin to get a positive opinion in the EU - and

[ Previous 5 results ] 4 5 6 7 8 9 10 11 12 13 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Streaming Well

Streaming Well is a healthcare-focused, award-winning video production company which operates in the US and Europe. We create engaging visual...

Latest intelligence

Empowered patients: shaking the foundations of healthcare
Precision medicine represents a new paradigm in healthcare.This new approach to treating and preventing disease views the patient holistically, analysing their genes, environment and lifestyle, and using this information to...
A uniquely English genomic medicine service
The UK National Health Service is developing one standardised approach to embedding precision medicine across the whole of England. Blue Latitude Health speaks to Dr Tom Fowler, Deputy Chief Scientist...
Blended Intelligence
Data is the most valued commodity of the modern world. For P&P it's all about the application....

Infographics